BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Journal Articles Oncotarget Year : 2016

BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia

Sabine Tricot
  • Function : Author
Xavier Leleu
  • Function : Author
  • PersonId : 989084

Abstract

Approximately 30% of the patients who fulfil the criteria of Waldenström's macroglobulinemia (WM) are diagnosed while asymptomatic (indolent), and will not require immediate therapy. Conversely, patients with a disease-related event will be considered for therapy. The physiopathology of these 2 groups remains unclear, and the mechanisms of progression from indolent to symptomatic WM have yet to be fully understood. Seventeen patients diagnosed with WM were included in this study, 8 asymptomatic WM (A-WM) and 9 symptomatic WM (S-WM). A differential analysis was performed on a first series of 11 patients and identified 48 genes whose expression separated samples from A-to S-WM. This gene signature was then confirmed on a second independent validation set of 6 WM. Within this expression profile, BACH2, a B-cell transcription factor known to be a tumor suppressor gene, was found to be over-expressed in A-MW relatively to S-MW. We specifically over-expressed BACH2 in a WM-related cell line and observed a significant reduction of the clonogenic activity. To the best of our knowledge, we report for the first time a specific gene expression signature that differentiates A-WM and S-WM. Within this expression profile, BACH2 was identified as a candidate gene that may help to understand better the behavior of tumor cells in indolent WM.
Fichier principal
Vignette du fichier
Herbaux2016.pdf (5.18 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

hal-01423307 , version 1 (29-12-2016)

Identifiers

  • HAL Id : hal-01423307 , version 1

Cite

Charles Herbaux, Elisabeth Bertrand, Guillemette Marot, Christophe Roumier, Nicolas Poret, et al.. BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia. Oncotarget, 2016. ⟨hal-01423307⟩
200 View
96 Download

Share

Gmail Facebook X LinkedIn More